Medifast, Inc. MED
12.59 USD +0.06 (+0.48%)
At closeNov 3, 2026, 4:01 PM EST
12.59 0.00 0.00%
After hours · Nov 3, 4:01 PM ET
12.51 Day range 12.85
9.22 52-week range 13.45
- YTD
- +17.88%
- 1 year
- +5.98%
- Market cap
- 140.79M
- Revenue (ttm)
- 674.48M
- Profit margin
- 1.09%
- EPS (ttm)
- -3.70
- Shares out
- 10.94M
- Forward P/E
- 56.17
- Dividend
- 6.60 (34.41%)
- Ex-dividend date
- Sep 17, 2023
- YTD return
- +17.88%
- 1-year return
- +5.98%
- Volume
- 123.78K
- Avg volume
- 141.18K
- Open
- 12.61
- Previous close
- 12.53
- Day's range
- 12.51 – 12.85
- 52-week range
- 9.22 – 13.45
- Beta
- 1.16
- Price target
- 16.50 (+31.1%)
1m -0.02 (-0.16%)
Key statistics
- Enterprise value
- 27.90M
- PEG ratio
- 0.00
- Price / sales
- 0.27
- Price / book
- 0.87
- Dividend yield
- 34.41%
- Payout ratio
- 0.00%
- Revenue growth
- -40.60%
- Free cash flow
- -7.09M
- Total cash
- 169.96M
- Total debt
- 17.63M
- Return on equity
- 3.66%
- Short % of float
- 22.52%
- 50-day average
- 18.72
- 200-day average
- 22.71
Analyst view
Price target (mean) 16.50 +31.1% upside
Now 12.59
- Target (low)
- 16.00
- Target (mean)
- 16.50
- Target (high)
- 17.00
Ratings (0m) 2 0 buy · 2 hold · 0 sell
- Strong buy0
- Buy0
- Hold2
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.16.
Financials — quick view
MED Revenue — quarterly 72.05M
MED Net income — quarterly -17.51M
MED EPS — quarterly -1.57
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2024 | Sep 1, 2024 | -0.15 | 0.35 | +0.50 | +333.33% |
| Aug 5, 2024 | Jun 1, 2024 | 0.36 | 0.92 | +0.56 | +155.56% |
| Apr 29, 2024 | Mar 1, 2024 | 0.78 | 0.66 | -0.12 | -15.38% |
| Feb 20, 2024 | Dec 1, 2023 | 0.99 | 1.09 | +0.10 | +10.10% |
| Nov 6, 2023 | Sep 1, 2023 | 1.02 | 2.12 | +1.10 | +107.84% |
| Aug 7, 2023 | Jun 1, 2023 | 1.44 | 2.77 | +1.33 | +92.36% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 5, 2024 | DA Davidson | up | Underperform | Neutral |
| Jul 22, 2024 | DA Davidson | main | Underperform | Underperform |
| Jun 5, 2024 | DA Davidson | down | Neutral | Underperform |
| Apr 30, 2024 | DA Davidson | main | Neutral | Neutral |
| Feb 21, 2024 | DA Davidson | main | Neutral | Neutral |
| Oct 13, 2023 | Stephens & Co. | init | — | Equal-Weight |
About Medifast, Inc.
Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.
- Sector
- Consumer Cyclical
- Industry
- Personal Services
- Country
- United States
- Website
- medifastinc.com
News
Medifast: 3 Key Takeaways for Long-Term Investors 
Medifast Is Running The Same Playbook, And I Have The Same Concerns 
Medifast Q3 Loss Narrower Than Expected as Coach Productivity Rises 
Medifast, Inc. (MED) Q3 2026 Earnings Call Transcript 
What Medifast (MED) Said on Its Q3 Earnings Call 
Medifast (MED) Reports Q3 Loss, Tops Revenue Estimates 
Medifast Q3 2026 Earnings Call Transcript 
Medifast Lowers FY2026 GAAP EPS Guidance from $(1.75)-$(0.25) to $(2.05)-$(1.80) vs $(0.94) Est - Medifast Sees FY2026 Adj EPS $(0.70)-$(0.45) vs $(0.94) Est; Raises FY2026 Sales Guidance from $270.000M-$300.000M to $280.000M-$300.000M vs $287.700M Est
Medifast Q3 Adj. EPS $(0.19) Beats $(0.35) Estimate, Sales $72.048M Beat $71.300M Estimate
Your note
Sign in to keep a note on MED — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BROWN JEFFREY J. | Director | Stock Award(Grant) | Jun 19, 2024 | 22,193 |
| CHARD DANIEL R | Chief Executive Officer | Stock Award(Grant) | Mar 12, 2024 | 211,828 |
| GEARY ELIZABETH A. | Director | Stock Award(Grant) | Jun 19, 2024 | 8,377 |
| HALLQUIST CONSTANCE J | Former | Sale | Oct 5, 2023 | 0 |
| HOER MICHAEL A. | Director | Stock Award(Grant) | Jun 19, 2024 | 14,971 |
| MACKENZIE JONATHAN BARRETT | Officer | Stock Award(Grant) | Mar 12, 2024 | 4,051 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 9.20% | 1,006,210 | 16.95M | Sep 29, 2024 |
| Blackrock Inc. | 8.01% | 876,114 | 14.76M | Sep 29, 2024 |
| Vanguard Group Inc | 6.64% | 726,167 | 12.24M | Sep 29, 2024 |
| AQR Capital Management, LLC | 3.52% | 384,598 | 6.48M | Sep 29, 2024 |
| Morgan Stanley | 2.93% | 321,007 | 5.41M | Sep 29, 2024 |
| Bank of America Corporation | 2.88% | 314,728 | 5.30M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.26% | 356,866 | 6.01M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.68% | 292,768 | 4.93M | Oct 30, 2024 |
| Avantis U.S. Small Cap Value ETF | 1.84% | 201,586 | 3.40M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.48% | 162,005 | 2.73M | Sep 29, 2024 |
| Vanguard Consumer Staples Index Fund | 1.17% | 127,545 | 2.15M | Aug 30, 2024 |
| Federated Hermes MDT Small Cap Core Fund | 1.15% | 125,563 | 2.12M | Jul 30, 2024 |